(“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced a first closing of $27 million (circa £22 million) in its Series E ...

Owlstone Medical has secured the first closing of its Series E financing round, securing $27m (approximately £22m) to advance ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

Marissa Antonio was 39-years-old when she was diagnosed with a 19cm liver tumour - and the nurse went on to issue a warning ...